Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
Antimicrobial Agents and Chemotherapy
|
September 25, 2003
In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization
Carolina Serena, Montserrat Ortoneda, Javier Capilla, et al.
Antimicrobial Agents and Chemotherapy
|
April 9, 2008
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum
Mónica Azor, Josepa Gené, Josep Cano, et al.
Pharmacotherapy
|
May 14, 2003
Enteral fluconazole population pharmacokinetics in patients in the surgical intensive care unit
Prabhu Rajagopalan, Robert K Pelz, Pamela A Lipsett, et al.
Antimicrobial Agents and Chemotherapy
|
March 5, 2009
Posaconazole therapeutic drug monitoring: a reference laboratory experience
George R Thompson, Michael G Rinaldi, Gennethel Pennick, et al.
Antimicrobial Agents and Chemotherapy
|
March 26, 2003
Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays
Gloria M González, Rolando Tijerina, Laura K Najvar, et al.
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians
|
July 30, 2003
Steady-state plasma concentrations of itraconazole after oral administration in Kemp's ridley sea turtles, Lepidochelys kempi
Charles A Manire, Howard L Rhinehart, Gennethel J Pennick, et al.
Journal of Clinical Microbiology
|
March 25, 2011
Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp
Jess F Peterson, Michael A Pfaller, Daniel J Diekema, et al.
Diagnostic Microbiology and Infectious Disease
|
August 4, 2012
Are epidemiologic cut-off values predictors of the in vivo efficacy of azoles in experimental aspergillosis?
Enrique Calvo, F Javier Pastor, Deanna A Sutton, et al.
Antimicrobial Agents and Chemotherapy
|
May 27, 2005
Caspofungin in combination with amphotericin B against Candida glabrata
Francesco Barchiesi, Elisabetta Spreghini, Annette W Fothergill, et al.
Antimicrobial Agents and Chemotherapy
|
January 28, 2009
Accelerated metabolism of voriconazole and its partial reversal by cimetidine
Brad Moriyama, Jason Elinoff, Robert L Danner, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
Antimicrobial Agents and Chemotherapy
|
September 25, 2003
In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization
Carolina Serena, Montserrat Ortoneda, Javier Capilla, et al.
Antimicrobial Agents and Chemotherapy
|
April 9, 2008
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum
Mónica Azor, Josepa Gené, Josep Cano, et al.
Pharmacotherapy
|
May 14, 2003
Enteral fluconazole population pharmacokinetics in patients in the surgical intensive care unit
Prabhu Rajagopalan, Robert K Pelz, Pamela A Lipsett, et al.
Antimicrobial Agents and Chemotherapy
|
March 5, 2009
Posaconazole therapeutic drug monitoring: a reference laboratory experience
George R Thompson, Michael G Rinaldi, Gennethel Pennick, et al.
Antimicrobial Agents and Chemotherapy
|
March 26, 2003
Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays
Gloria M González, Rolando Tijerina, Laura K Najvar, et al.
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians
|
July 30, 2003
Steady-state plasma concentrations of itraconazole after oral administration in Kemp's ridley sea turtles, Lepidochelys kempi
Charles A Manire, Howard L Rhinehart, Gennethel J Pennick, et al.
Journal of Clinical Microbiology
|
March 25, 2011
Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp
Jess F Peterson, Michael A Pfaller, Daniel J Diekema, et al.
Diagnostic Microbiology and Infectious Disease
|
August 4, 2012
Are epidemiologic cut-off values predictors of the in vivo efficacy of azoles in experimental aspergillosis?
Enrique Calvo, F Javier Pastor, Deanna A Sutton, et al.
Antimicrobial Agents and Chemotherapy
|
May 27, 2005
Caspofungin in combination with amphotericin B against Candida glabrata
Francesco Barchiesi, Elisabetta Spreghini, Annette W Fothergill, et al.
Antimicrobial Agents and Chemotherapy
|
January 28, 2009
Accelerated metabolism of voriconazole and its partial reversal by cimetidine
Brad Moriyama, Jason Elinoff, Robert L Danner, et al.
Page
of 8